End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
18.44 CNY | +0.05% | -7.10% | -16.11% |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
Strengths
- Analysts expect a sharply increasing business volume for the group, with high growth rates in the coming years.
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
Weaknesses
- Based on current prices, the company has particularly high valuation levels.
- The company appears highly valued given the size of its balance sheet.
- The company is highly valued given the cash flows generated by its activity.
- The company is not the most generous with respect to shareholders' compensation.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
Ratings chart - Surperformance
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-16.11% | 1B | - | ||
-6.41% | 12.2B | B+ | ||
-4.07% | 8.22B | B- | ||
+5.77% | 5.72B | B | ||
+28.32% | 5.42B | C | ||
-59.76% | 2.7B | D+ | ||
+8.04% | 2.63B | - | - | |
-6.47% | 2.38B | B- | ||
+22.20% | 2.1B | C | ||
-8.15% | 1.81B | D+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 300685 Stock
- Ratings Amoy Diagnostics Co., Ltd.